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Background: Pathologic diagnosis of stage I idiopathic membranous nephropathy (MN-I) requires electron
microscopy or immunohistochemistry that shows a glomerular capillary staining pattern of IgG and C3. However, it
is not uncommon that renal biopsy did not obtain sufficient material for electron microscopy and that IgG and C3
staining in glomeruli largely lost at biopsy due to corticosteroid treatment. Since C3d is one of the final
degradation products of C3 that is more stable in vivo, we determine if C3d staining could be used as a novel
immunohistochemical marker for MN-I.
Methods and results: 74 MN-I patients with electron microscopy proven MN-I were examined by
immunoperoxidase staining of C3d. Intensive C3d staining was present in glomerular capillary like the staining
pattern of IgG and C3 in MN-I. Importantly, in 40 MN-I patients who underwent corticosteroid treatment at biopsy
the intensity and glomerular capillary pattern of C3d staining remained largely intact while the staining for IgG had
substantially reduced and the pattern of glomerular capillary staining became unrecognizable.
Conclusions: C3d glomerular capillary staining may be a novel marker for pathologic diagnosis of MN-I that is
continuously present at biopsy in patient who has received corticosteroid treatment.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/2120780075734479
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Pathologic diagnosis of stage I idiopathic membranous
nephropathy (MN-I) requires electron microscopy since
the disease exhibits minimal glomerular change under
optical microscopy. However, in clinical practice, it is
not uncommon that biopsy materials are not sufficient
to process for electron microscopy. Immunofluorescence
or immunoperoxidase staining for immunoglobulin G
(IgG) and complement 3 (C3), which show a typical pat-
tern of capillary staining for membranous nephropathy
(MN), has been recommended in the absence of electron* Correspondence: 768203566@qq.com
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reproduction in any medium, provided the ormicroscopy to help for differential and final diagnosis.
The problem is that corticosteroid treatment usually
have been initiated in most of patients before biopsy and
the treatment often quickly leads to substantial decrease
or disappear of immune depositions of IgG and C3.
Thus, it is important to find another immune deposit
marker that shows the same capillary pattern as IgG and
C3 in MN, but remains detectable at biopsy even
patients have started corticosteroid therapy. Activation
of complement pathways plays a critical role in podocyte
injury in MN. C3 is the most abundant complement
protein that is essential at both classical and alternative
complement pathways. C3 becomes activated after it is
cut to C3a and C3b two parts by C3 convertase(s). In-
activation of C3b by its degradation enzymes results inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nostaining of C3d has been widely applied to renal and
liver transplant biopsies to help for acute rejection diag-
nosis [1-4]. An increase in C3d mesangial staining has
also been reported in IgA nephropathy [5-7]. Addition-
ally, there was a report of positive C3d staining in glom-
eruli of patients with MN [8]. Since our preliminary
examination showed the presence of capillary C3d
immunostaining like C3 and IgG in glomeruli of MN-I,
we further examined if C3d could be used as an immune
deposit marker for MN-I even after patients have been
treated for a period with corticosteroid.
Methods
Case selection
Our department received 5110 renal biopsy specimes be-
tween June 2009 and July 2010 from 20 hospitals around
China. The study was approved by the hospital’s Ethics
and Research Committee. MN was diagnosed in 303
cases (5.9%) and 74 cases (24.4%) were MN-I. Among 74
MN-I, 40 patients have started corticosteroid therapy be-
fore biopsy (Group A) while 34 patients had not (Group
B). 20 cases of mild mesangioproliferative glomerulo-
nephritis (m-MsPGN) (Group C) and 10 cases of min-
imal change disease (MCD) were selected as controls for
studying immunostaining pattern of C3d. Normal kidney
sections were also examined.
Pathologic criteria
The renal biopsies were examined by optical microscopy,
immunohistochemistry and electron microscopy. Sec-
tions for optical microscopy were stained with Haema-
toxylin and Eosin, Periodic acid–Schiff (PAS), Periodic
acid-silver Methenamine and Masson’s Trichrom (PAM-
Masson) stains. A minimal of eight glomeruli was re-
quired for pathological examination. The diagnosis of
MN-I included minimal change in glomerular basement
membranes under optical microscopy and IgG immu-
nostaining showing a typical pattern of capillary staining
and focal foot process effacement and focal subepithelial
immune deposit under electron microscopy.
Immunohistochemistry
Immunostaining for C3d was performed using the EliVi-
sionTM system (Maixin. Biocompany, Fuzhou China). Bri-
fely, deparaffinized sections were put in stainless steel
pressure cooker with citrate buffer (pH 6.0) heating for
antigen retrieval, following with 0.1% trypsin (Becton
Dickinson and Company, USA) digestion for 90 s. En-
dogenous peroxidase activity was blocked with 3% hydro-
gen peroxide for 10 min. Tissues then were incubated
with first antibody, rabbit polyclonal against C3d
(ab15981, 1:1000, abcam, USA) for 2 h. After reacting with
a polymer enhancer at 37°C for 20 min, tissues wereincubated with a secondary anbtibody, an anti-rabbit im-
munoglobulin conjugated with peroxidase-labeled dextran
polymer (Maixin Biocompany, Fuzhou, China) 37°C for
30 min. Positive staining was revealed by immersing the
sections in an aminoethyl carbazole substrate solution
(ZSGB Biocompany, Fuzhou, China), followed by nuclear
staining with hematoxylin [9].
In order to confirm the effect of using high-pressure
heating and trypsin for antigen retrieval in C3d immuno-
histochemical staining, we chose serial sections of paraf-
fin-embedded tissue of stage II idiopathic membranous
nephropathy (MN-II) with no retrieval, either high-
pressure heating or trypsin retrieval and high-pressure
heating plus trypsin retrieval, respectively. Negative con-
trol was set in each group and primary antibody was
replaced by phosphate-buffered saline (PBS).
Since C3c is another degradation product of C3b, we
also performed immunostaining for C3c to compare with
C3d for staining pattern and their presence after cortico-
steroid treatment. Immunostaining for IgG, IgM, IgA, and
C1q were also performed. A semiquantitative measure-
ment of the staining area was performed. A score of 0 to 3
was defined as: 0, no staining (negative); 1, < 25% of glom-
erulus stained (+, weak); 2, 25% to 50% glomerulus stained
(++, moderate); 3, >50% glomerulus stained (+++, strong)
[4,10,11].
Statistical analysis
Values are expressed as mean ± SD. Results were analyzed
by nonparametric test, chi-square test and Fisher’s exact
probability test using SPSS 16.0 software. A P value of less
than 0.05 was considered statistical significance.
Results
Characteristics of patients and renal pathology
Demographic profile such as age and sex and clinical
presentations such as proteinuria were similar between
MN-I patients treated without or with corticosteroid be-
fore biopsy (Table 1). Similar amount of proteinuria be-
tween treated and untreated patients suggests that
corticosteroid treatment had not been effective at the
time. Clinical features of m-MsPGN patients were also
listed on Table 1. Histological findings for MN-I patients
included slight dilatation of the glomerular capillary
lumens with basement membranes showing slightly stiff-
ness but normal thickness. Podocytes appeared swollen.
Under transmission electron microscope, there were
sparse, minute, subepithelial deposits. Focal foot process
effacement could be seen (data not shown).
C3d
Deposition of C3d in glomeruli was examined by immu-
noperoixdase staining. C3d staining was essentially nega-
tive in normal kidney glomeruli (data not shown). A
Table 1 Clinic characteristics of the three groups of patients
Group A (n=40) Group B (n=34) Group C (n=20)
Sex (male/female) 20/20 17/17 12/8
Age (years) 45.50 ± 14.82 46.79 ± 13.62 24.95 ± 14.10
Time to biopsy (days) 113.90± 105.46 55.03 ± 63.67 59.85 ± 78.60
Steroid treatment (%) 100 0 65
MAP (mmHg) 94.45 ± 10.00 92.78 ± 10.81 88.42 ± 10.23
Hematuria (%) 0 0 5
Proteinuria (g/24 h) 5.80 ± 3.15 4.21 ± 2.37 3.72 ± 3.47
SCr(umol/L) 74.89 ± 26.42 59.34 ± 13.03 77.01 ± 37.94
BUN(mmol/L) 5.27 ± 1.59 3.89 ± 1.06 5.37 ± 1.88
Group A: patients treated with corticosteroid before biopsy.
Group B: patients treated without corticosteroid before biopsy.
Group C: patients with mild mesangioproliferative glomerulonephritis.
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of MN-I patients who have not received corticosteroid
therapy at biopsy (Figure 1A). The staining in MN-I
glomeruli showed a predominantly capillary pattern like
the pattern of IgG staining (Figure 1B). Immunostaining
for C3c, another degradation product of C3b, showed
similar capillary pattern like C3d in MN-I but was with
much lesser intensity (Figure 1C).
We further evaluated the presence and pattern of C3d
staining in glomeruli of MCD and m-MsPGN. C3d stain-
ing was seen in part of mesangium in MCD (Figure 2A).
The mesangial staining was more obvious in m-MsPGN
and the staining occasionally was extended to glomerular
capillary (Figure 2B). Nevertheless, the staining pattern of
C3d in both MCD and m-MsPGN was mostly mesangiumC
A B
Figure 1 Glomerular C3d, IgG and C3c staining in MN-I. A, A strong C3
staining in glomeruli showed a predominantly capillary pattern. C, Stainingdominant and was clearly different from capillary pattern
found in MN-I (Figure 2C).
It is known that glomerular staining of IgG and C3 in
MN-I would largely reduce and the pattern of capillary
staining became either unrecognizable or largely lost after
corticosteroid therapy. To determine if this would also be
the case for C3d, we compared the intensity and staining
pattern of C3d in biopsy samples from patients treated
with and without corticosteroid, and also compared the
incidence of C3d, C3c and IgG staining. As expected, the
staining for glomerular IgG in MN-I was substantially
reduced and capillary pattern of staining had largely lost
after corticosteroid treatment (Figure 3D). C3c staining
was disappeared (Figure 3E). On the contrary, C3d stain-
ing remained as strong and glomerular capillary stainingd staining was universally present in glomerular capillary. B, The IgG
for C3c showing similar capillary pattern but much lesser intensity.
A B
C
Figure 2 Different pattern of glomerular C3d staining in minimal change disease, m-MsPGN and MN-I. A, C3d staining was seen in part
of mesangium in minimal change disease. B, The mesangial staining was more obvious in m-MsPGN. C, Staning for C3d showed predominantly
capillary pattern in MN-I.
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ticosteroid (Figure 3F). Figure 3A, Figure 3B and
Figure 3C showed IgG, C3c and C3d staining in biopsy
samples from patients treated without corticosteroid, re-
spectively. As shown in Table 2, group A showed a signifi-
cantly higher incidence of C3d and the intensity of C3d
was also significantly stronger than that of IgG and C3c
(P <0.01). Moreover, the incidence of IgG and C3c were
significantly higher in group B than group A, the intensity
of IgG and C3c were significantly stronger in group B,A B
D E
Figure 3 Glomerular IgG, C3d, and C3c staining in MN-I after corticoid
and without corticosteroid, respectively. B,E, C3c staining pattern treated w
with and without corticosteroid, respectively.compared to group A (P <0.01). However, no differences
for intensity and incidence of C3d were found between
group A and group B.
Antigen retrieval effect
Cases of MN-II with high-pressure heating plus trypsin
retrieval, C3d staining was strongly positive in capillary
loop, no backgroud (Figure 4B). With no antigen re-
trieval, C3d staining was faintly positive (Figure 4D).
With trypsin retrieval, C3d staining was weakly positiveC
F
treatment. A,D, IgG in biopsy samples from patients treated with
ith and without corticosteroid, respectively. C,F, C3d in MN-I treated
Table 2 The results of immunohistochemistry examination in group A and group B
Positive part IgG IgM IgA C3c C3d C1q
Group A (n = 40) capillary lumens 0.95 ± 1.11 (52.5%) 0 0 0.03 ± 0.16 (3.33%) 3.00 ± 0.00 (100%)a 0
Group B (n = 34) capillary lumens 2.94 ± 0.24 (100%)b 0 0 0.29 ± 0.58(23.5%)b 3.00 ± 0.00 (100%) 0
Group A: patients treated with corticosteroid before biopsy.
Group B: patients treated without corticosteroid before biopsy.
a P <0.01 versus IgG and C3c in the same group; b P <0.01 versus group A.
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was moderately positive (Figure 4H), and Controls were
negative (Figure 4C, 4E, 4G and 4I). Figure 4A showed
the PAM-Masson stain study.
Discussion
Due to its minor change under optical microscopy, the
diagnosis of MN-I depends largely on electron micros-
copy. However, some biopsy materials may not be suffi-
cient for electron microscope examination. For instance,
we received 5110 renal biopsy specimens from hospitals
all over the China between June 2009 and July 2010, of
which 1328 cases (26.0%) did not have sufficient tissue
for electron microscopy. Immune complex formation in
subepithelial and resultant complement activation has
been implicated in the pathogenesis of MN. A typical
glomerular capillary pattern of IgG and C3 depositions
is present in patients with MN. Since IgG and C3 stain-
ing are largely negative in MCD and show predomin-
antly a pattern of mesangial staining in m-MsPGN, two
diseases with minimal changes under optical microscopy
like MN-I, IgG and C3 immunostaining are very helpful
for differential diagnosis amongst MN-I, MCD and m-
MsPGN when electron microscopy is missing. However,A B C
F G H
Figure 4 C3d immunohistochemical staining in serial sections of para
region with A, with high-pressure heating plus trypsin retrieval, C3d stainin
positive in the global sclerotic glomerulus. C. With high-pressure heating p
control. D. With no antigen retrieval, C3d was faintly positive. E. The negati
weakly positive. G. The negative control with trypsin retrieval. H.With high-
control with high-pressure heating retrieval.the staining intensity and pattern of IgG and C3 are sig-
nificantly affected by corticosteroid treatment. In this
study, we found an exclusively positive and strong glom-
erular capillary IgG staining in biopsy samples obtained
from MN-I patients untreated with corticosteroid. In bi-
opsy samples obtained from MN-I patients have been
treated with corticosteroid, however, only 52.5% of tis-
sues showed a weak IgG glomerular staining and the ca-
pillary staining pattern became largely unrecognizable in
most of patients.
C3b is one of the cleavage products of C3 that plays a
critical role in activating both classical and alternative
pathways of complement. C3b is degraded stepwise to
inactive C3b and then to C3c and C3dg. C3d is a final
cleavage product of C3dg and is a stable marker of com-
plement activation that binds covalently to cell surfacess
and basement membrance, so it can persist for a long
time in the tissue. C3d deposition has been found in
patients with MN [7]. We examined glomerular staining
of both C3c and C3d in MN-I patients. Although both
C3c and C3d are final degradation products of C3b, the
intensity of C3c glomerular staining was substantially
weaker than C3d. This may be due to the problem of
anti-C3c antibody or a shorter half-life of C3c [12,13].D E
I
ffin-embedded tissue of MN-II. A. PAM-Masson stain. B. The same
g was strongly positive in capillary loop, no backgroud. C3d was also
lus trypsin retrieval, primary antibody was replaced by PBS as negative
ve control with no antigen retrieval. F. With trypsin retrieval, C3d was
pressure heating retrieval, C3d was moderately positive. I. The negative
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corticosteroid treatment. Both intensity and incidence of
C3c glomerular staining was substantially reduced in MN-
I patients treated with corticosteroid at biopsy. In contrast,
C3d glomerular staining was strong and showed a typical
capillary pattern in MN-I and remained largely unchanged
by corticosteroid therapy. Additionally, we found that the
completely sclerosing glomeruli showed C3d-positive
(Figure 4B), which indicating that C3d could persist for a
long time in the tissue and didn’t disappear. Since glom-
erular staining of C3d is either negative or shows a mesan-
gial dominantly pattern in patients with MCD and m-
MsPGN, C3d immunostaining could be applied as a good
immune deposit marker for pathologic diagnosis of MN-I,
especially in condition that patient has been treated with
corticosteroid. Since corticosteroid treatment seemed
largely ineffective judged by the present of intensive pro-
teinuria in MN-I patients included in this study, it is un-
clear if C3d staining would remain in patients after
successful corticosteroid treatment. Additionally, the mo-
lecular basis of different intensity and pattern of C3c and
C3d glomerular staining in MN-I patients is unknown.
The C3d staining results of comparison showed that
the use of high-pressure heating and trypsin for antigen
retrieval can get the best staining results. With no anti-
gen retrieval C3d staining was faintly positive. With
trypsin retrieval C3d staining was weakly positive. With
high-pressure heating retrieval C3d staining was moder-
ately positive. Controls showed negative. These results
suggested that antigen retrieval twice can improve the
renal biopsy paraffin-embeded tissues by immuoperoxi-
dase method and does not cause false positive and back-
ground staining.
Conclusions
In summary, our study suggests that C3d glomerular ca-
pillary staining may be a novel marker for pathologic
diagnosis of MN-I that is continuously present at biopsy
in patient who has received corticosteroid treatment.
This finding is particularly significant when there are no
sufficient biopsy materials to process for electron mi-
croscopy which is considered to be the gold standard for
the diagnosis of MN.
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